1 |
BÄRTSCH P, GIBBS J S R. Effect of altitude on the heart and the lungs[J]. Circulation, 2007, 116(19): 2191-2202.
|
2 |
AKSEL G, ÇORBACıOĞLU Ş K, ÖZEN C. High-altitude illness: management approach[J]. Turk J Emerg Med, 2019, 19(4): 121-126.
|
3 |
MALLET R T, BURTSCHER J, RICHALET J P,et al.Impact of high altitude on cardiovascular health: current perspectives[J]. Vasc Health Risk Manag, 2021, 17: 317-335.
|
4 |
LIU Y H, ZOU J, LI B G, et al. RUNX3 modulates hypoxia-induced endothelial-to-mesenchymal transition of human cardiac microvascular endothelial cells[J]. Int J Mol Med, 2017, 40(1): 65-74.
|
5 |
TAKESHITA S, KIKUNO R, TEZUKA K, et al. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin Ⅰ[J]. Biochem J, 1993, 294(Pt 1): 271-278.
|
6 |
MATHEW R. Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity[J]. Am J Physiol Heart Circ Physiol, 2014, 306(1): H15-H25.
|
7 |
NIE X W, SHEN C Y, TAN J X, et al. Periostin: a potential therapeutic target for pulmonary hypertension? [J].Circ Res, 2020, 127(9): 1138-1152.
|
8 |
FAN B T, LIU X H, CHEN X W, et al. Periostin mediates condylar resorption via the NF-κB-ADAMTS5 pathway[J]. Inflammation, 2020, 43(2): 455-465.
|
9 |
HUANG X F, TANG L, WANG F, et al. Astragaloside Ⅳ attenuates allergic inflammation by regulation Th1/Th2 cytokine and enhancement CD4(+)CD25(+)Foxp3 T cells in ovalbumin-induced asthma[J]. Immunobiology, 2014, 219(7): 565-571.
|
10 |
SUN L, LI W P, LI W Z, et al. Astragaloside Ⅳ prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF‑κB pathway under high glucose conditions[J]. Int J Mol Med, 2014, 34(1): 167-176.
|
11 |
LU M L, LENG B, HE X, et al. Calcium sensing receptor-related pathway contributes to cardiac injury and the mechanism of astragaloside Ⅳ on cardioprotection[J]. Front Pharmacol, 2018, 9: 1163.
|
12 |
FAN N, LIU C, REN M. Effect of different high altitudes on vascular endothelial function in healthy people[J]. Medicine, 2020, 99(11): e19292.
|
13 |
LENG B, ZHANG Y J, LIU X R,et al.Astragaloside Ⅳ suppresses high glucose-induced NLRP3 inflammasome activation by inhibiting TLR4/NF-κB and CaSR[J]. Mediators Inflamm, 2019, 2019: 1082497.
|
14 |
JANASZAK-JASIECKA A, SIEKIERZYCKA A, BARTOSZEWSKA S, et al. eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells[J].Angiogenesis,2018,21(4):711-724.
|
15 |
SHARMA P, DONG Y, SOMERS V K, et al. Intermittent hypoxia regulates vasoactive molecules and alters insulin-signaling in vascular endothelial cells[J]. Sci Rep, 2018, 8(1): 14110.
|
16 |
LEE B, SHIN H, OH J E, et al. An autophagic deficit in the uterine vessel microenvironment provokes hyperpermeability through deregulated VEGFA, NOS1, and CTNNB1[J]. Autophagy, 2021, 17(7): 1649-1666.
|
17 |
SUN Y, LU M L, SUN T R, et al. Astragaloside Ⅳ attenuates inflammatory response mediated by NLRP-3/calpain-1 is involved in the development of pulmonary hypertension[J]. J Cell Mol Med,2021,25(1): 586-590.
|
18 |
CONTIÉ S, VOORZANGER-ROUSSELOT N, LITVIN J, et al. Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases[J]. Int J Cancer, 2011, 128(2): 352-360.
|
19 |
OUYANG G L, LIU M, RUAN K, et al. Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway[J]. Cancer Lett, 2009, 281(2): 213-219.
|
20 |
JANASZAK-JASIECKA A, SIEKIERZYCKA A, PŁOSKA A, et al. Endothelial dysfunction driven by hypoxia-the influence of oxygen deficiency on NO bioavailability[J]. Biomolecules, 2021, 11(7): 982.
|
21 |
LIU G X, XI H Q, SUN X Y, et al. Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis[J].World J Gastroenterol,2015,21(9): 2605-2613.
|
22 |
IMOTO K, OKADA M, YAMAWAKI H. Periostin mediates right ventricular failure through induction of inducible nitric oxide synthase expression in right ventricular fibroblasts from monocrotaline-induced pulmonary arterial hypertensive rats[J]. Int J Mol Sci, 2018, 20(1): 62.
|